Example: bankruptcy

SAFETY DATA SHEET - Verven - Peintures

Noxyde SAFETY data SHEETP roduct nameNoxyde Product Details of the supplier of the SAFETY data type:e-mail address of person responsible for this SDS:Product Relevant identified uses of the substance or mixture and uses advised againstIndustrial usesProfessional usesIdentified usesSECTION 1: Identification of the substance/mixture and of the company/undertakingConsumer useProduct is not intended for consumer advised Emergency telephone numberSupplierTelephone number:Hours of operation:Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Regulation (EU) No.

Noxyde SAFETY DATA SHEET Product name Noxyde : 1.1 Product identifier 1.3 Details of the supplier of the safety data sheet Product type :Liquid. e-mail address of person

Tags:

  Sheet, Data, Safety, Safety data sheet

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of SAFETY DATA SHEET - Verven - Peintures

1 Noxyde SAFETY data SHEETP roduct nameNoxyde Product Details of the supplier of the SAFETY data type:e-mail address of person responsible for this SDS:Product Relevant identified uses of the substance or mixture and uses advised againstIndustrial usesProfessional usesIdentified usesSECTION 1: Identification of the substance/mixture and of the company/undertakingConsumer useProduct is not intended for consumer advised Emergency telephone numberSupplierTelephone number:Hours of operation:Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Regulation (EU) No.

2 Europe - Martin Mathys NV, Kolenbergstraat 23, B-3545 Zelem, BelgiumTelephone no.: +32 (0) 13 460 200 Fax no.: +32 (0) 13 460 20124 / 7+44 (0) 207 858 1228 See Section 11 for more detailed information on health effects and according to Regulation (EC) No. 1272/2008 [CLP/GHS]SECTION 2: Hazards Classification of the substance or mixtureProduct definition:MixtureSee Section 16 for the full text of the H statements declared Label elementsHazard pictograms:Skin Sens. 1B, H317 Aquatic Chronic 2, H411 The product is classified as hazardous according to Regulation (EC) 1272/2008 as of issue/Date of revision:9/11/2017 Date of previous issue:9/11/2017 Version:41/15 Noxyde Conforms to Regulation (EC) No.

3 1907/2006 (REACH), Annex II, as amended by Regulation (EU) No. 2015/830 SECTION 2: Hazards identificationHazardous ingredients:Poly[oxy(methyl-1,2-ethanedi yl)], -(methylphenyl)- -hydroxy-:Other hazards which do not result in classificationNone word:Hazard statements:Prevention:Precautionary statementsResponse:Storage:Disposal:Warn ingMay cause an allergic skin to aquatic life with long lasting - Avoid breathing vapour or - Wear protective gloves: - nitrile rubber glovesP273 - Avoid release to the - IF ON SKIN:P352 - Wash with plenty of soap and - If skin irritation or rash occurs.

4 P313 - Get medical - Dispose of contents and container in accordance with all local, regional,national and international label elementsContainers to be fitted with child-resistant fasteningsNot warning of dangerNot applicable.:::Contains: Reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC ] and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1).Special packaging Other hazardsGeneral:Not XVII - Restrictions on the manufacture,placing on the market and use of certain dangerous substances, mixtures and articles:Restricted to professional 3: Composition/information on ingredientsIdentifiersProduct/ingredient nametrizinc bis(orthophosphate)REACH #:02-2119485044-40EC: 231-944-3 CAS: 7779-90-0 Index: 030-011-00-6 10 Aquatic Acute 1, H400 (M=1)Aquatic Chronic 1, H410 (M=1)[1]Poly[oxy(methyl-1,2-ethanediyl)] , -(methylphenyl)- -hydroxy-REACH #:02-2119549982-25 CAS: 9064-13-5 3 Skin Sens.

5 1B, H317[1]zinc oxideREACH #:01-2119463881-32EC: 215-222-5 CAS: 1314-13-2 Index: 030-013-00-7 3 Aquatic Acute 1, H400 (M=1)Aquatic Chronic 1, H410 (M=1)[1]%TypeRegulation (EC) No. 1272/2008 [CLP] Mixtures:MixtureDate of issue/Date of revision:9/11/2017 Date of previous issue:9/11/2017 Version:42/15 Noxyde Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Regulation (EU) No. 2015/830 SECTION 3: Composition/information on ingredientsSee Section 16 for the full text of the H statements declared exposure limits, if available, are listed in Section are no additional ingredients present which, within the current knowledge of the supplier and in the concentrations applicable, are classified as hazardous to health or the environment, are PBTs, vPvBs or Substances of equivalent concern, or have been assigned a workplace exposure limit and hence require reporting in this section.

6 [1] Substance classified with a health or environmental hazard[2] Substance with a workplace exposure limit[3] Substance meets the criteria for PBT according to Regulation (EC) No. 1907/2006, Annex XIII[4] Substance meets the criteria for vPvB according to Regulation (EC) No. 1907/2006, Annex XIII[5] Substance of equivalent concernTypeIf swallowed, seek medical advice immediately and show the container or person warm and at rest. Do NOT induce contact lenses, irrigate copiously with clean, fresh water, holding the eyelids apart for at least 10 minutes and seek immediate medical contaminated clothing and shoes.

7 Wash skin thoroughly with soap and water or use recognised skin cleanser. Do NOT use solvents or to fresh air. Keep person warm and at rest. If not breathing, if breathing is irregular or if respiratory arrest occurs, provide artificial respiration or oxygen by trained 4: First aid measuresGeneralIn all cases of doubt, or when symptoms persist, seek medical attention. Never give anything by mouth to an unconscious person. If unconscious, place in recovery position and seek medical advice.:There are no data available on the mixture itself. The mixture has been assessed following the conventional method ofthe CLP Regulation (EC) No 1272/2008 and is classified for toxicological properties accordingly.

8 See Sections 2 and 3 for to component solvent vapour concentrations in excess of the stated occupational exposure limit may resultin adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on thekidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscularweakness, drowsiness and, in extreme cases, loss of may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with themixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorptionthrough the splashed in the eyes, the liquid may cause irritation and reversible takes into account, where known, delayed and immediate effects and also chronic effects of components fromshort-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye Poly[oxy(methyl-1,2-ethanediyl)], -(methylphenyl)- -hydroxy-, Reaction mass of.

9 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1). May produce anallergic Description of first aid measuresIngestionInhalationEye contact::::Protection of first-aiders:No action shall be taken involving any personal risk or without suitable training. It may be dangerous to the person providing aid to give mouth-to-mouth contaminated clothing thoroughly with water before removing it, or wear Most important symptoms and effects, both acute and delayedOver-exposure signs/symptomsEye contact:No specific data .

10 :No specific contact:Adverse symptoms may include the following:irritationrednessDate of issue/Date of revision:9/11/2017 Date of previous issue:9/11/2017 Version:43/15 Noxyde Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Regulation (EU) No. 2015/830 SECTION 4: First aid measuresSee toxicological information (Section 11)Notes to physicianTreat symptomatically. Contact poison treatment specialist immediately if large quantities have been ingested or inhaled.:Specific Indication of any immediate medical attention and special treatment neededNo specific treatment.


Related search queries